Compartir
Información de la revista
Número
Vol. 27. Núm. 4.(julio - agosto 2022)
Editorials
Clues to decipher the origin of severe acute hepatitis in children: a new enigma during the COVID-19 pandemic
Misael Uribe, Arturo Panduro, Gisela DuPont, Nora A. Fierro
Ann Hepatol. 2022;27:100731
Open access
Opinions
Endohepatology: current status and perspectives
Félix I. Téllez-Ávila, Mauricio García-Saenz-de-Sicilia
Ann Hepatol. 2022;27:100730
Open access
Concise reviews
The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis
Na He, Gong Feng, Shuai Hao, Meiqi Xu, Jing Liu, Fanjiao Kong, Zhuoxu Ren, Wenli Dou, ... Juan Wang
Ann Hepatol. 2022;27:100705
Open access
Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
Jiali Chen, Kun He, Yunwei Han, Lu Guo, Ke Su, Zhenying Wu
Ann Hepatol. 2022;27:100710
Open access
Original articles
The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology
Jialu Jiang, Zhiping Yang, Guoxin Hou, Xuming Yao, Jin Jiang
Ann Hepatol. 2022;27:100701
Open access
microRNA-122 inhibits hepatic stellate cell proliferation and activation in vitro and represses carbon tetrachloride-induced liver cirrhosis in mice
Jing Ma, Qiqian Zhao, Mengxuan Chen, Weihang Wang, Bo He, Yongfang Jiang, Yi Li
Ann Hepatol. 2022;27:100700
Open access
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Ann Hepatol. 2022;27:100699
Open access
IGF-1 contributes to liver cancer development in diabetes patients by promoting autophagy
Yuying Shan, Caide Lu, Jiacheng Wang, Mingyao Li, Shazhou Ye, Shengdong Wu, Jing Huang, Shizhong Bu, Fuyan Wang
Ann Hepatol. 2022;27:100697
Open access
Non-invasive methods for iron overload evaluation in dysmetabolic patients
Paula Pessin Fábrega Branisso, Claudia Pinto Marques Souza de Oliveira, Hilton Muniz Leão Filho, Fabiana Roberto Lima, Aritânia Sousa Santos, Marcio Correa Mancini, Maria Edna de Melo, Flair José Carrilho, ... Cintia Cercato
Ann Hepatol. 2022;27:100707
Open access
Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease
Joshua J. Cook, Madeline Wei, Benny Segovia, Ludmila Cosio-Lima, Jeffrey Simpson, Scott Taylor, Yunsuk Koh, Sangho Kim, Youngil Lee
Ann Hepatol. 2022;27:100709
Open access
Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites
Thomas Deleuran, Hugh Watson, Hendrik Vilstrup, Peter Jepsen
Ann Hepatol. 2022;27:100711
Open access
Establishment of a scoring model for early diagnosis of infection associated with liver failure
Wenhui Liu, Yonglan Pu, Chuanwu Zhu, Ailan Qin
Ann Hepatol. 2022;27:100713
Open access
Position papers
Position statement on the use of albumin in liver cirrhosis
Graciela Castro-Narro, Carlos Moctezuma-Velázquez, Rene Male-Velázquez, Rafael Trejo-Estrada, Francisco Javier Bosques, Rosalba Moreno-Alcántar, Heriberto Rodríguez-Hernández, Aleida Bautista-Santos, ... Aldo Torre
Ann Hepatol. 2022;27:100708
Open access
Brief reports
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Ann Hepatol. 2022;27:100702
Open access
Letters to the editor
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
Somayeh Shokri, Shahab Mahmoudvand
Ann Hepatol. 2022;27:100704
Open access
Understanding the cellular and molecular mechanisms of hepatic fibrosis is essential for basic and clinical researchers
Erika Ramos-Tovar, Pablo Muriel
Ann Hepatol. 2022;27:100732
Open access
Publique en
Annals of Hepatology
Affiliated societies
